Indapamide Taj SR 1.5 mg Sustained-release Tablets | indapamide and alcohol indapamide weight loss stopping indapamide indapamide reviews indapamide side effects nhs indapamide 1.5 mg indapamide uses indapamide dose
الرئيسية » من نحن » الرسالةالرسالةتنشط مؤسسة رفيق الحريري في ميادين التربية والتعليم والثقافة والرعاية الصحية والاجتماعية، بغية اعداد مواطنين مؤهلين معرفيا، مسلحين بقيم المواطنة ومبادئ حقوق الانسان لكي ينخرطوا لاحقاً في العملية التنموية على الصعيدين الوطني والعالمي، متكئين لهذه الغاية على ما يحصلونه من عمق المعرفة في شتى الاختصاصات ومختلف الثقافات، وما يكتسبونه من مهارات العمل وما يحظون به من تكافؤ الفرص.
الرئيسية » من نحن » الرسالة
الرسالة
تنشط مؤسسة رفيق الحريري في ميادين التربية والتعليم والثقافة والرعاية الصحية والاجتماعية، بغية اعداد مواطنين مؤهلين معرفيا، مسلحين بقيم المواطنة ومبادئ حقوق الانسان لكي ينخرطوا لاحقاً في العملية التنموية على الصعيدين الوطني والعالمي، متكئين لهذه الغاية على ما يحصلونه من عمق المعرفة في شتى الاختصاصات ومختلف الثقافات، وما يكتسبونه من مهارات العمل
Indapamide Taj SR 1.5 mg Sustained-release
Tablets
PATIENT INFORMATION LEAFLET
Indapamide Taj SR 1.5mg Sustained-Release Tablets
Indapamide
Read all of this leaflet carefully before you start taking this
medicine because it contains important information for you.
·
Keep this leaflet. You
may need to read it again.
·
If you have any
further questions, ask your doctor or pharmacist.
·
This medicine has been
prescribed for you only. Do not pass it on to others. It may harm them, even if
their signs of illness are the same as yours.
·
If you get any side
effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
What is in this leaflet
1. What Indapamide Taj SR 1.5mg Sustained-Release Tablets are
and what they are used for
2. What you need to know before you take Indapamide Taj SR 1.5mg Sustained-Release Tablets
3. How to take Indapamide Taj SR 1.5mg Sustained-Release Tablets
4. Possible side effects
5. How to store Indapamide Taj SR 1.5mg Sustained-Release Tablets
6. Contents of the pack and other information
2. What you need to know before you take Indapamide Taj SR 1.5mg Sustained-Release Tablets
3. How to take Indapamide Taj SR 1.5mg Sustained-Release Tablets
4. Possible side effects
5. How to store Indapamide Taj SR 1.5mg Sustained-Release Tablets
6. Contents of the pack and other information
1. What Indapamide Taj SR 1.5mg Sustained-Release
Tablets are and what they are used for
The active substance in Indapamide Taj SR 1.5mg Sustained-Release
Tablets is indapamide. Indapamide belongs to a class of medicines called
“diuretics” which increase urine production by the kidneys.
It is used to treat high blood pressure (essential
hypertension).
2. What you need to know before you take Indapamide
Taj SR 1.5mg Sustained-Release Tablets
Do not take Indapamide Taj SR 1.5mg Sustained-Release Tablets if
you:
·
are allergic to
indapamide or any of the other ingredients of this medicine
·
are allergic to
other medicines in the same chemical class as Indapamide (“Sulfonamides”), such
as trimethoprim or Co-trimoxazole
·
have severe
liver disease or a condition called Hepatic Encephalopathy (damage
to the brain and nerves which can occur as a complication of liver problems)
·
have severe
kidney disease
·
have been told by your
doctor that you have low levels of potassium in your blood
Warnings and precautions
Talk to your doctor or pharmacist before taking Indapamide Taj SR
1.5mg Sustained-Release Tablets if you suffer from or have previously suffered
from any of the following:
·
Heart disease, heart failure or heart rhythm
problems
·
Diabetes (please check your blood sugar levels
regularly)
·
Gout
·
Kidney problems
·
Liver problems
Indapamide affects the levels of potassium and sodium in the
blood. Your doctor may conduct blood tests to monitor levels of potassium and
sodium in your blood before and during your treatment. This is especially
important in patients, who are at high risk to develop electrolyte disturbances
(such as elderly, patients who are taking many medicines or malnourished
patients).
Indapamide may increase the sensitivity of your skin to sunlight.
If this happens you should tell your doctor as he/she may decide to stop your
treatment. In case of an administration of Indapamide, it is recommended to
protect exposed areas to the sun or to artificial UVA.
If the function of your parathyroid gland is to be examined:
tell your doctor, who will suspend your treatment with Indapamide.
Athletes should be aware that Indapamide may give a positive
reaction in drug tests.
If you think any of these situations may apply to you or you
have any questions or doubts about taking your medicine, you should consult
your doctor or pharmacist.
Other medicines and Indapamide Taj SR 1.5mg Sustained-Release
Tablets
Tell your doctor or pharmacist if you are taking, have recently
taken or might take any other medicines.
The effects of Indapamide may be altered or undesirable effects
may occur if you are also taking the following medicines. Talk to your doctor
if you are taking any of the following:
Combinations that are not recommended:
·
Lithium (used in the treatment of depression):
you should not take Indapamide with lithium due to the risk of increased levels
of lithium in the blood with signs of overdose.
Combinations requiring precautions for use:
Torsade des pointes (special form of heart rhythm disorders) may
be induced by taking:
·
Medicines
used in the treatment of irregular heart beat such as Quinidine, Hydroquinidine, Disopyrimide,
Amiodarone, Sotalol, Dofetilide or Ibutilide
·
Medicines
used in the treatment of Psychoses such as Chlorpromazine, Cyamemazine, Levomepromazine,
Thioridazine, Trifluoperazine, Amisulpride, Sulpiride, Sultopride, Tiapride,
Droperidol or Haloperidol
·
Various
other drugs such as Bepridil
(used for the treatment of Angina), Cisapride and Diphemanil (used for the
treatment of gastro-intestinal problems), Intravenous Erythromycin,
Pentamidine, Moxifloxacin, sparfloxacin (used for treatment of infection),
Halofantrine (used for the treatment of Malaria), Mizolastine (used in the
treatment of allergy), intravenous Vincamine (used to treat circulatory
problems in the brain)
Non-Steroidal anti-inflammatory drugs (sometimes called N.S.A.I.D’s) used in
the treatment of pain and inflammation (e.g. Ibuprofen, Diclofenac and
Indometacin), including selective Cyclooxygenase-2 (COX-2) inhibitors (such as
Celecoxib, Etoricoxib) and high doses of Aspirin (3g or more a day):
·
Possible reduction in
the blood pressure lowering effect of indapamide. Risk of acute kidney failure
in patients with decreased body water (dehydration). Adequate fluid intake is
essential.
ACE inhibitors used to treat high blood pressure and heart failure (e.g.
Captopril, Enalapril, Perindopril):
Risk of a severe reduction in blood pressure and/or acute kidney
failure when treatment with an ACE inhibitor is started in patients with
pre-existing sodium depletions (particularly in patients with Renal Artery
Stenosis)
The effect of indapamide may be altered or undesirable effects
may occur if you are also taking any of the following:
·
Metformin (used in the treatment of diabetes)
·
Baclofen (used in the treatment of muscle spasm)
·
Ciclosporin and Tacrolimus (used
for the treatment of auto-immune disorders or to suppress the immune system
following a transplant)
·
Steroids (e.g. Prednisolone, Hydrocortisone or
Fludrocortisone) used to treat various conditions including severe Asthma and
Rheumatoid Arthritis
·
stimulant laxatives
(e.g. Senna)
·
some medicines
used to treat heart failure and some heart rhythm disorders (e.g.
Digoxin, Digitoxin)
·
Some potassium-sparing
diuretics (water tablets) such as Amiloride, Spironolactone,
Triamterene
·
certain water
tablets which may cause a decrease of blood potassium levels such as
Bendroflumethiazide, Furosemide, Piretanide, Bumetanide and Xipamide
·
Some Antidepressants
(e.g. Imipramine), Neuroleptics (used to treat mental disorders)
·
Some Iodine
containing medicines (used in the diagnosis of some illnesses)
·
Tetracosactide (used
in the diagnosis of some illnesses and treatment of gastro-intestinal problems)
·
Medicines containing calcium
Indapamide Taj SR 1.5mg Sustained-Release Tablets with food and
drink
Food and drink have no impact on the way that your medicine
works. You may take it with or after food or on an empty stomach.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant
or are planning to have a baby, ask your doctor or pharmacist for advice before
taking this medicine.
Pregnancy
This medicine is not recommended during pregnancy. Please tell
your doctor if you are pregnant or wish to become pregnant.
Breast-feeding
The active ingredient is excreted in milk. Breastfeeding is not
advisable if you are taking this medicine. Ask your doctor or pharmacist for
advice before taking any medicine.
Driving and using machines
Indapamide lowers blood pressure which may make you feel
light-headed and dizzy in relation to the decrease in blood pressure, especially
at the start of the treatment or when another antihypertensive is added. If
affected do not drive or operate heavy machinery.
Indapamide Taj SR 1.5mg Sustained-Release Tablets contain
lactose
Your medicine contains the sugar lactose. If you have been told
by your doctor that you have an intolerance to some sugars, contact your doctor
before taking this medicinal product.
3. How to take Indapamide Taj SR 1.5mg Sustained-Release
Tablets
Always take this medicine exactly as your doctor or pharmacist
has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is 1 tablet per day which should preferably
be taken in the morning.
Method of administration
Your tablets should be swallowed whole with a sufficient amount
of water (such as a glass of water). Do not crush or chew the tablets.
Indapamide can be taken without regard to meals.
Patients with impaired renal function
Patients with severe renal failure (creatinin-clearance below 30
ml/min) must not be treated with Indapamide (see section 2. “Do not
take Indapamide Taj SR 1.5mg Sustained-Release Tablets if you:”). Thiazide
and related diuretics are fully effective only when renal function is normal or
only minimally impaired.
Patients with impaired liver function
Patients with severe hepatic impairment must not be treated with
Indapamide (see section 2. “Do not take Indapamide Taj SR 1.5mg Sustained-Release
Tablets if you:”).
Elderly
Elderly patients can be treated with Indapamide when renal
function is normal or only minimally impaired.
Use in children and adolescents
Indapamide is not recommended for use in children and
adolescents due to a lack of data on safety and efficacy.
Duration of treatment:
The duration of treatment will be decided by the treating
doctor. If you have the impression that the effect of Indapamide is too strong
or too weak, talk to your doctor or pharmacist.
If you take more Indapamide Taj SR 1.5mg Sustained-Release
Tablets than you should
In case of an overdose, there will be an increased rate of side
effects, an increased diuretic effect with a risk of blood pressure drop and
disturbances of the water and electrolyte balance. If you have accidentally
taken more Indapamide than you should, contact your doctor immediately for
advice. Symptoms of an overdose may include nausea, vomiting, low blood
pressure (leading to lightheadedness), cramps, dizziness, drowsiness,
confusion, excessive production of urine or low production of urine.
If you forget to take Indapamide Taj SR 1.5mg Sustained-Release
Tablets
If you forget to take a tablet then take it as soon as you
remember. Do not take a double dose to make up for a forgotten dose.
If you stop taking Indapamide Taj SR 1.5mg Sustained-Release
Tablets
Treatment for high blood pressure is normally life-long. You
should not stop taking your medicine without discussing it with your doctor
first.
If you have any further questions on the use of this medicine,
ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects,
although not everybody gets them.
Common (may affect up
to 1 in 10 people)
·
Allergic reaction
(especially in people who tend to have allergic or Asthmatic reactions) leading
to skin rashes with macules and papules
Uncommon (may
affect up to 1 in 100 people)
·
Vomiting
·
Allergic reaction
(especially in people who tend to have allergic or Asthmatic reactions) leading
to purple spots or patches on the skin
Rare (may affect up
to 1 in 1,000 people)
·
Dizziness (vertigo)
·
Tiredness
·
Headache
·
Pins and needles
(paraesthesiae)
·
Nausea (feeling sick)
·
Constipation
(infrequent bowel movements; hard, dry stools)
·
Dry mouth
Very rare (may
affect up to 1 in 10,000 people)
·
Reduction in blood
platelets, which increases risk of bleeding or bruising
·
Reduction in the
number of white blood cells, which makes infections more likely; which may be
severe (agranulocytosis)
·
Reduction in levels of
certain blood cells which can cause weakness, bruising or make infections more
likely (Haemolytic Anaemia); Aplastic Anaemia (a bone marrow depression)
·
Inflammation of the
pancreas, which causes severe pain in the abdomen and back (Pancreatitis)
·
Irregular heart beat
·
Low blood pressure,
which may cause lightheadedness
·
Kidney problems
·
Liver problems
(detected by blood tests)
·
Increases in the
levels of calcium in your blood
·
Serious allergic
reactions (Angioedema, especially in people who tend to have allergic or
Asthmatic reactions) with swelling of the face, lips or tongue and nettle rash,
swelling of the mucous membranes of the throat or airways resulting in
shortness of breath or difficulty of swallowing. If this occurs, contact your
doctor immediately.
·
Serious allergic
reaction with flu like symptoms, blistering of the skin, mouth, eyes and
genital organs (Toxic Epidermic Necrolysis, Stevens Johnson Syndrome). If this
occurs, contact your doctor immediately.
Not known (frequency
cannot be estimated from the available data)
·
Indapamide may cause
low levels of sodium and potassium in your blood. Your doctor may monitor these
levels via blood tests (see above – “Warnings and precautions”).
·
Indapamide may cause
decreased blood volume (Hypovolaemia) with dehydration and fall in the blood
pressure on standing up (Orthostatic Hypotension).
·
Indapamide may cause
low levels of chloride in the blood, which may lead to Metabolic Alkalosis (low
acidity of the blood).
·
Indapamide may cause
increased blood sugar levels.
·
If you have existing
liver problems, taking Indapamide may cause a condition called Hepatic
Encephalopathy (damage to the brain and nerves which can occur as a
complication of liver disease).
·
If you suffer from a
condition called “Acute Disseminated Lupus Erythmatosus” (rare, widespread
inflammatory disease), taking Indapamide may worsen the disease.
·
Taking Indapamide may
make your skin more sensitive to UV light (see “Warnings and precautions”
above).
·
Indapamide may cause
high levels of uric acid in the blood leading to gout attacks.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or
nurse. This includes any possible side effects not listed in this leaflet. You
can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information
on the safety of this medicine.
5. How to store Indapamide Taj SR 1.5mg Sustained-Release
Tablets
Keep this medicine out of the sight and reach of children.
This medicinal product does not require any special storage
conditions.
Do not use this medicine after the expiry date stated on the
carton and container. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household
waste. Ask your Pharmacist how to throw away medicines you no longer use. These
measures will help protect the environment.
6. Contents of the pack and other information
What Indapamide Taj SR 1.5mg Sustained-Release Tablets contain
·
The active substance
is indapamide. Each Sustained-release tablet contains 1.5mg of indapamide.
·
The other ingredients
are:
Tablet core: lactose monohydrate, starch, pregelatinised; hypromellose, silica, colloidal anhydrous magnesium stearate (vegetable).
Tablet coating: hypromellose, macrogol 6000, titanium dioxide (E171).
Tablet core: lactose monohydrate, starch, pregelatinised; hypromellose, silica, colloidal anhydrous magnesium stearate (vegetable).
Tablet coating: hypromellose, macrogol 6000, titanium dioxide (E171).
What Indapamide Taj SR 1.5mg Sustained-Release Tablets look like
and contents of the pack
Indapamide Taj SR 1.5mg Sustained-Release Tablets are white to
off white, round, biconvex Sustained-release, film-coated tablets.
Indapamide Taj SR 1.5mg Sustained-Release Tablets are available
in packs containing 30 Sustained-release tablets in blister packs (PVC /
aluminium).
Manufacturer
TAJ PHARMACEUTICALS
LTD.
Mumbai, India
This leaflet was last revised in October 2016
Rafik Hariri Foundation operates in the domains of Education, Culture and Social & Health Care Services in order to qualify the Lebanese youth with multidisciplinary and multicultural knowledge, work skills, civic education, principles of human rights and equal opportunities; all being requisites to contribute to the viability of the national and global development processes.
Contact Us
Rafic Hariri Foundation
Tel : 00961 1 853 055 - 60
Fax : 00961 1 853 006
P.O.Box. : 13 / 5171 Chouran - Beirut 1102 - 2020
Beirut - Lebanon
Website : www.rhf.org.lb
E-mail : rhf@rafichariri-foundation.org
الرئيسية » من نحن » الرسالة
الرسالة
تنشط مؤسسة رفيق الحريري في ميادين التربية والتعليم والثقافة والرعاية الصحية والاجتماعية، بغية اعداد مواطنين مؤهلين معرفيا، مسلحين بقيم المواطنة ومبادئ حقوق الانسان لكي ينخرطوا لاحقاً في العملية التنموية على الصعيدين الوطني والعالمي، متكئين لهذه الغاية على ما يحصلونه من عمق المعرفة في شتى الاختصاصات ومختلف الثقافات، وما يكتسبونه من مهارات العمل
Comments
Post a Comment